Please login to the form below

Not currently logged in
Email:
Password:

90TEN bolsters medical education team

Agency appoints Melanie Sobczyk and Mark Lakeram

Mark and MelHealthcare communications consultancy 90TEN has appointed Melanie Sobczyk and Mark Lakeram to its medical education team following a year of growth.

Sobczyk joins the agency as an associate director from Chameleon, where she was the group account director. Her new role will see her take responsibility for the medical education client services team.

Lakeram also joins the agency as its editorial director, a newly created role which will see him lead and shape the team responsible for delivering editorial excellence across the consultancy. He is a former pharmacist and has held an associate editorial director role at Medical Knowledge Group, the medical division of Hill+Knowlton Strategies.

Alison Doughty, managing director of medical education at 90TEN, said: “Out clients come to us for our scientific expertise and strategic acumen, and both Mark and Melanie have these in spades.

“I’m delighted to be working with such a strong and talented senior team during this very exciting time for us here at 90TEN.

10th August 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...